Aetion
Overview
Real-world evidence analytics company whose Aetion Evidence Platform applies causal inference and rigorous epidemiologic methods to generate transparent, reproducible evidence on treatment safety, effectiveness, and value. Serves biopharma, medical device companies, and regulators including the FDA and EMA.
Notable
Known for the FDA RCT-DUPLICATE demonstration project replicating clinical trials with RWD; acquired by Datavant in July 2025 to form an end-to-end RWE platform.
Key services
- Aetion Evidence Platform (AEP) software
- regulatory-grade RWE studies
- comparative effectiveness and safety analyses
- Aetion Activate for code and no-code analysts
Subcategories
Verified Reviews
No verified reviews yet — are you a customer of Aetion? Share your experience in a short, confidential interview.
Share your experience